What are the major opportunities in the Drug Repurposing market? What are the strategies for the Drug Repurposing market?

For detailed insights on the major opportunities and strategies in the Drug Repurposing market, Read More

How does the Drug Repurposing market relate to the overall economy and other similar markets?

For detailed insights on Drug Repurposing's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Drug Repurposing market growth? SWOT analysis of the Drug Repurposing market.

For detailed insights on the key dynamics influencing the Drug Repurposing market growth and SWOT analysis of the Drug Repurposing industry, Read More

Global Drug Repurposing Market Report 2025

Item added to cart!

Published : December 2025

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF

Purchase This Report

Drug Repurposing Global Market Report 2025

Name: Drug Repurposing Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Type (Disease-Centric, Target-Centric, Drug-Centric), By Drug Molecules (Biologics, Small Molecule), By Therapeutic Area (Oncology, Neurology, Infectious Diseases, Cardiovascular Diseases, Autoimmune Disorders), By Route Of Administration (Oral, Intravenous, Topical, Inhalation, Intramuscular), By End-User (Pharmaceutical Companies, Research And Academic Institutes, Contract Research Organizations) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Drug Repurposing Market Overview

• Drug Repurposing market size has reached to $34.12 billion in 2024

• Expected to grow to $53.42 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%

• Growth Driver: Surge In Age-Related Brain Disorders Fueling The Growth Of The Market Due To Increased Life Expectancy

• Market Trend: AI-Powered Drug-Protein Interaction Modeling Revolutionizes Repurposing

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Drug Repurposing Market?

Drug repurposing is the process of identifying new therapeutic uses for existing or previously failed drugs. It leverages known safety profiles and pharmacology to reduce development time and cost. The purpose is to efficiently bring treatments to market by bypassing early-stage drug discovery steps.

The main types of drug repurposing are disease-centric, target-centric, and drug-centric. Disease-centric refers to repurposing drugs by focusing on a specific disease and testing various existing drugs to see if they can treat that disease, regardless of their original target. The multiple drug molecules involved are biologics and small molecules. The various therapeutic areas include oncology, neurology, infectious diseases, cardiovascular diseases, and autoimmune disorders through various routes of administration: oral, intravenous, topical, inhalation, and intramuscular, and cater to several end users such as pharmaceutical companies, research and academic institutes, and contract research organizations.

Drug Repurposing Market Size and growth rate 2025 to 2029: Graph

What Is The Drug Repurposing Market Size 2025 And Growth Rate?

The drug repurposing market size has grown strongly in recent years. It will grow from $34.12 billion in 2024 to $37.38 billion in 2025 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to the rising cost of novel drug development, increasing drug failures in clinical trials, a rise in demand for faster drug approval, increasing availability of off-patent drugs, and rising government and academic research funding.

What Is The Drug Repurposing Market Growth Forecast?

The drug repurposing market size is expected to see strong growth in the next few years. It will grow to $53.42 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to increasing demand for cost-effective therapies, growing investments from pharmaceutical companies, increasing collaborations among biotech firms, and expanding applications in oncology and neurology. Major trends in the forecast period include advancements in computational drug discovery tools, advanced use of AI and ML in drug repurposing, innovation in predictive modeling for drug efficacy, integration of big data analytics in drug screening, and advancements in biomarker identification.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Drug Repurposing Market Segmented?

1) By Type: Disease-Centric, Target-Centric, Drug-Centric

2) By Drug Molecules: Biologics, Small Molecule

3) By Therapeutic Area: Oncology, Neurology, Infectious Diseases, Cardiovascular Diseases, Autoimmune Disorders

4) By Route Of Administration: Oral, Intravenous, Topical, Inhalation, Intramuscular

5) By End-User: Pharmaceutical Companies, Research And Academic Institutes, Contract Research Organizations

Subsegments:

1) By Disease-Centric: Phenotypic Screening, Epidemiological Analysis, Clinical Observation-Based Repurposing

2) By Target-Centric: Protein Target Modulation, Pathway Modulation, Biomarker-Based Targeting

3) By Drug-Centric: Off-Target Activity Identification, Structure-Based Drug Repositioning, Adverse Effect-Based Repurposing

What Is Driving The Drug Repurposing Market? Surge In Age-Related Brain Disorders Fueling The Growth Of The Market Due To Increased Life Expectancy

The growing prevalence of neurodegenerative diseases is expected to propel the growth of the drug repurposing market going forward. Neurodegenerative diseases refer to a group of disorders characterized by the progressive loss of structure or function of neurons, including their death. The rise in neurodegenerative diseases such as alzheimer's dementia is due to increased life expectancy, as aging is the primary risk factor that contributes to the gradual decline of neuronal function over time. Drug repurposing helps neurodegenerative diseases by identifying existing drugs with known safety profiles that can be redirected to target disease pathways, accelerating the development of effective treatments. For instance, in March 2023, according to the Alzheimer's Association, a US-based nonprofit voluntary health organization, in 2023, about 6.7 million Americans aged 65 and older are living with Alzheimer's dementia, with projections indicating an increase to 13.8 million by 2060. Therefore, the growing prevalence of neurodegenerative diseases is driving the growth of the drug repurposing industry.

Who Are The Major Players In The Global Drug Repurposing Market?

Major companies operating in the drug repurposing market are F. Hoffmann-La Roche Ltd , International Business Machines Corporation (IBM), Bayer AG, Takeda Pharmaceutical Company Limited, Amgen Inc., Teva Pharmaceutical Industries Limited, Astellas Pharma Inc., UCB S.A., Eisai Co Ltd., Celltrion Inc., Alnylam Pharmaceuticals Inc., Evotec SE, BenevolentAI Limited, Insilico Medicine Inc., Cosmos Health Inc., Recursion Pharmaceuticals Inc., Pharnext S.A., Healx Ltd., Algernon Pharmaceuticals Inc., BioXcel Therapeutics Inc.

What Are The Key Trends Of The Global Drug Repurposing Market? AI-Powered Drug-Protein Interaction Modeling Revolutionizes Repurposing

Major companies operating in the drug repurposing market are focusing on developing advanced technologies such as artificial intelligence (AI)-powered drug-protein interaction modeling to accelerate the identification of new therapeutic uses for existing drugs. Artificial intelligence (AI)-powered drug-protein interaction modeling leverages artificial intelligence and machine learning to predict how drugs interact with proteins across the human proteome, using expansive datasets to enhance accuracy and confidence. For instance, in July 2025, Cosmos Health Inc., a US-based healthcare company, unveiled Cloudscreen 2.0, an advanced AI platform for drug repurposing. It is a next-generation system designed to process datasets over 100 times larger than before, enabling comprehensive analysis of drug-protein interactions. By incorporating mutagenesis data and tools for analyzing disordered proteins, the platform targets diseases such as cancer, obesity, and diabetes. Additionally, graphics processing unit (GPU)-based cloud computing empowers scalable processing, making the platform a critical innovation in accelerating research and development pipelines for drug repurposing across multiple therapeutic areas.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Drug Repurposing Market? Predictive Oncology Partnered With YA II PN, Ltd. To Advance AI-Driven Drug Discovery And Repurposing

In July 2025, Predictive Oncology Inc., a US-based artificial intelligence-driven drug discovery and repurposing company, partnered with YA II PN, Ltd., to secure a $10 million share purchase agreement. Through this partnership, Predictive Oncology aims to advance its AI-driven platform to accelerate the identification of new therapeutic uses for existing drugs and streamline oncology drug discovery processes. YA II PN, Ltd. is a US-based investment fund managed by Yorkville Advisors Global, LP, a US-based investment management services providing financing to support initiatives.

What Is The Regional Outlook For The Global Drug Repurposing Market?

North America was the largest region in the acute care telemedicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Acute Care Telemedicine Market?

The acute care telemedicine market includes revenues earned by entities by providing services like virtual emergency care, remote intensive care unit monitoring, tele-stroke evaluations, virtual hospitalist support, and real-time specialist consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Drug Repurposing Industry?

The drug repurposing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including drug repurposing industry global market size, regional shares, competitors with the market share, market segments, market trends and opportunities, and any further data you may need to thrive in the drug repurposing industry. This drug repurposing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Author : Abhilash Pyata

Drug Repurposing Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$37.38 billion
Revenue Forecast In 2034	$53.42 billion
Growth Rate	CAGR of 9.3% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	Type, Drug Molecules, Therapeutic Area, Route Of Administration, End-User, Disease-Centric, Target-Centric, Drug-Centric
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	F. Hoffmann-La Roche Ltd , International Business Machines Corporation (IBM), Bayer AG, Takeda Pharmaceutical Company Limited, Amgen Inc., Teva Pharmaceutical Industries Limited, Astellas Pharma Inc., UCB S.A., Eisai Co Ltd., Celltrion Inc., Alnylam Pharmaceuticals Inc., Evotec SE, BenevolentAI Limited, Insilico Medicine Inc., Cosmos Health Inc., Recursion Pharmaceuticals Inc., Pharnext S.A., Healx Ltd., Algernon Pharmaceuticals Inc., BioXcel Therapeutics Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Drug Repurposing Market Characteristics

3. Drug Repurposing Market Trends And Strategies

4. Drug Repurposing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Drug Repurposing Growth Analysis And Strategic Analysis Framework

5.1. Global Drug Repurposing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Drug Repurposing Market Growth Rate Analysis

5.4. Global Drug Repurposing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Drug Repurposing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Drug Repurposing Total Addressable Market (TAM)

6. Drug Repurposing Market Segmentation

6.1. Global Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Disease-Centric

Target-Centric

Drug-Centric

6.2. Global Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Biologics

Small Molecule

6.3. Global Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oncology

Neurology

Infectious Diseases

Cardiovascular Diseases

Autoimmune Disorders

6.4. Global Drug Repurposing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Intravenous

Topical

Inhalation

Intramuscular

6.5. Global Drug Repurposing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pharmaceutical Companies

Research And Academic Institutes

Contract Research Organizations

6.6. Global Drug Repurposing Market, Sub-Segmentation Of Disease-Centric, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Phenotypic Screening

Epidemiological Analysis

Clinical Observation-Based Repurposing

6.7. Global Drug Repurposing Market, Sub-Segmentation Of Target-Centric, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Protein Target Modulation

Pathway Modulation

Biomarker-Based Targeting

6.8. Global Drug Repurposing Market, Sub-Segmentation Of Drug-Centric, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Off-Target Activity Identification

Structure-Based Drug Repositioning

Adverse Effect-Based Repurposing

7. Drug Repurposing Market Regional And Country Analysis

7.1. Global Drug Repurposing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Drug Repurposing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Drug Repurposing Market

8.1. Asia-Pacific Drug Repurposing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Drug Repurposing Market

9.1. China Drug Repurposing Market Overview

9.2. China Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Drug Repurposing Market

10.1. India Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Drug Repurposing Market

11.1. Japan Drug Repurposing Market Overview

11.2. Japan Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Drug Repurposing Market

12.1. Australia Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Drug Repurposing Market

13.1. Indonesia Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Drug Repurposing Market

14.1. South Korea Drug Repurposing Market Overview

14.2. South Korea Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Drug Repurposing Market

15.1. Western Europe Drug Repurposing Market Overview

15.2. Western Europe Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Drug Repurposing Market

16.1. UK Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Drug Repurposing Market

17.1. Germany Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Drug Repurposing Market

18.1. France Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Drug Repurposing Market

19.1. Italy Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Drug Repurposing Market

20.1. Spain Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Drug Repurposing Market

21.1. Eastern Europe Drug Repurposing Market Overview

21.2. Eastern Europe Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Drug Repurposing Market

22.1. Russia Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Drug Repurposing Market

23.1. North America Drug Repurposing Market Overview

23.2. North America Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Drug Repurposing Market

24.1. USA Drug Repurposing Market Overview

24.2. USA Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Drug Repurposing Market

25.1. Canada Drug Repurposing Market Overview

25.2. Canada Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Drug Repurposing Market

26.1. South America Drug Repurposing Market Overview

26.2. South America Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Drug Repurposing Market

27.1. Brazil Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Drug Repurposing Market

28.1. Middle East Drug Repurposing Market Overview

28.2. Middle East Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Drug Repurposing Market

29.1. Africa Drug Repurposing Market Overview

29.2. Africa Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Drug Repurposing Market Competitive Landscape And Company Profiles

30.1. Drug Repurposing Market Competitive Landscape

30.2. Drug Repurposing Market Company Profiles

30.2.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis

30.2.2. International Business Machines Corporation (IBM) Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Drug Repurposing Market Other Major And Innovative Companies

31.1. Teva Pharmaceutical Industries Limited

31.2. Astellas Pharma Inc.

31.3. UCB S.A.

31.4. Eisai Co Ltd.

31.5. Celltrion Inc.

31.6. Alnylam Pharmaceuticals Inc.

31.7. Evotec SE

31.8. BenevolentAI Limited

31.9. Insilico Medicine Inc.

31.10. Cosmos Health Inc.

31.11. Recursion Pharmaceuticals Inc.

31.12. Pharnext S.A.

31.13. Healx Ltd.

31.14. Algernon Pharmaceuticals Inc.

31.15. BioXcel Therapeutics Inc.

32. Global Drug Repurposing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Drug Repurposing Market

34. Recent Developments In The Drug Repurposing Market

35. Drug Repurposing Market High Potential Countries, Segments and Strategies

35.1 Drug Repurposing Market In 2029 - Countries Offering Most New Opportunities

35.2 Drug Repurposing Market In 2029 - Segments Offering Most New Opportunities

35.3 Drug Repurposing Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Drug Repurposing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Drug Repurposing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Drug Repurposing Market, Sub-Segmentation Of Disease-Centric, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Drug Repurposing Market, Sub-Segmentation Of Target-Centric, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Drug Repurposing Market, Sub-Segmentation Of Drug-Centric, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Drug Repurposing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Drug Repurposing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: F. Hoffmann-La Roche Ltd Financial Performance

Table 80: International Business Machines Corporation (IBM) Financial Performance

Table 81: Bayer AG Financial Performance

Table 82: Takeda Pharmaceutical Company Limited Financial Performance

Table 83: Amgen Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Drug Repurposing Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Drug Repurposing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Drug Repurposing Market, Sub-Segmentation Of Disease-Centric, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Drug Repurposing Market, Sub-Segmentation Of Target-Centric, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Drug Repurposing Market, Sub-Segmentation Of Drug-Centric, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Drug Repurposing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Drug Repurposing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Drug Repurposing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Drug Repurposing Market, Segmentation By Drug Molecules, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Drug Repurposing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: F. Hoffmann-La Roche Ltd Financial Performance

Figure 80: International Business Machines Corporation (IBM) Financial Performance

Figure 81: Bayer AG Financial Performance

Figure 82: Takeda Pharmaceutical Company Limited Financial Performance

Figure 83: Amgen Inc. Financial Performance

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Music Therapy Global Market Report 2025 – By Type (Receptive, Active), By Application (Traumatic, Chronic Pain, Substance Abuse Disorder, Neurodevelopment Disorder), By End-User (School, Hospital, Rehabilitation Center, ...

Personal Development Global Market Report 2025 – By Instruments (E-Platform, Workshops And Seminars, Books, Personal Training And Coaching), By Focus Area (Mental Health, Motivation And Inspiration, Physical Health, Self...

Nicotine Addiction Treatment Global Market Report 2025 – By Type (Pharmacological, Therapies, Other Types ), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy ), By End-User (Generation Z, Mill...

Drug Device Combination Global Market Report 2025 – By Product( Auto-Injector, Microneedle Patch, Digital Pill, Smart Inhaler, Drug Delivery Hydrogels, Drug-Eluting Lens, Other Products), By Distribution Channel( Direct ...

Drug Discovery Global Market Report 2025 – By Drug Type (Small Molecule, Large Molecule), By Process (Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization, Candidate Validation), By Technolo...

Pharmaceutical Drug Delivery Global Market Report 2025 – By Route of Administration (Oral, Ocular, Pulmonary, Nasal, Injectable, Topical, Other Routes), By Application (Infectious Diseases, Cancer, Cardiovascular Disease...

Animal Drug Compounding Global Market Report 2025 – By Animal Type (Companion Animals, Livestock Animals), By Product (Anti-infective Agents, Anti-inflammatory Agents, Hormones And Substitutes, CNS Agents, Other Products...

Frequently Asked Questions

What is the definition of the Drug Repurposing market?

How will the Drug Repurposing market drivers and restraints affect the market dynamics? What forces will shape the Drug Repurposing industry going forward?

The Drug Repurposing market major growth driver - Surge In Age-Related Brain Disorders Fueling The Growth Of The Market Due To Increased Life Expectancy. For further insights on the Drug Repurposing market, request a sample here

What is the forecast market size or the forecast market value of the Drug Repurposing market?

The Drug Repurposing market size has grown strongly in recent years. The drug repurposing market size has grown strongly in recent years. It will grow from $34.12 billion in 2024 to $37.38 billion in 2025 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to the rising cost of novel drug development, increasing drug failures in clinical trials, a rise in demand for faster drug approval, increasing availability of off-patent drugs, and rising government and academic research funding. The drug repurposing market size is expected to see strong growth in the next few years. It will grow to $53.42 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to increasing demand for cost-effective therapies, growing investments from pharmaceutical companies, increasing collaborations among biotech firms, and expanding applications in oncology and neurology. Major trends in the forecast period include advancements in computational drug discovery tools, advanced use of AI and ML in drug repurposing, innovation in predictive modeling for drug efficacy, integration of big data analytics in drug screening, and advancements in biomarker identification. For further insights on the Drug Repurposing market, request a sample here

How is the Drug Repurposing market segmented?

The drug repurposing market covered in this report is segmented –
1) By Type: Disease-Centric, Target-Centric, Drug-Centric
2) By Drug Molecules: Biologics, Small Molecule
3) By Therapeutic Area: Oncology, Neurology, Infectious Diseases, Cardiovascular Diseases, Autoimmune Disorders
4) By Route Of Administration: Oral, Intravenous, Topical, Inhalation, Intramuscular
5) By End-User: Pharmaceutical Companies, Research And Academic Institutes, Contract Research Organizations Subsegments:
1) By Disease-Centric: Phenotypic Screening, Epidemiological Analysis, Clinical Observation-Based Repurposing
2) By Target-Centric: Protein Target Modulation, Pathway Modulation, Biomarker-Based Targeting
3) By Drug-Centric: Off-Target Activity Identification, Structure-Based Drug Repositioning, Adverse Effect-Based Repurposing For further insights on the Drug Repurposing market, request a sample here

Which region has the largest share of the Drug Repurposing market? What are the other regions covered in the report?

North America was the largest region in the drug repurposing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug repurposing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Drug Repurposing market, request a sample here.

Who are the major players in the Drug Repurposing market?

What are the key trends in the Drug Repurposing market?

Major trends in the Drug Repurposing market include AI-Powered Drug-Protein Interaction Modeling Revolutionizes Repurposing. For further insights on the Drug Repurposing market, request a sample here.